UY39567A - Compuestos pirazol que contienen boro,composiciones que los comprenden, métodos y usos de los mismos - Google Patents
Compuestos pirazol que contienen boro,composiciones que los comprenden, métodos y usos de los mismosInfo
- Publication number
- UY39567A UY39567A UY0001039567A UY39567A UY39567A UY 39567 A UY39567 A UY 39567A UY 0001039567 A UY0001039567 A UY 0001039567A UY 39567 A UY39567 A UY 39567A UY 39567 A UY39567 A UY 39567A
- Authority
- UY
- Uruguay
- Prior art keywords
- methods
- pyrazole compounds
- compositions
- contain boron
- jano
- Prior art date
Links
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052796 boron Inorganic materials 0.000 title abstract 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 108091000080 Phosphotransferase Proteins 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 102000020233 phosphotransferase Human genes 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003217 pyrazoles Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos pirazol que contienen boro, o sus sales farmacéuticamente aceptables, composiciones farmacéuticas que los contienen y sus usos médicos. Los compuestos de la invención tienen actividad como inhibidores de las quinasas Jano (JAK), útiles en el tratamiento o el control de la inflamación, enfermedades autoinmunes, cáncer y otros trastornos e indicaciones en los que sería deseable la modulación de las JAK. También se describen métodos para tratar la inflamación, enfermedades autoinmunes, cáncer y otras afecciones que son susceptibles a la inhibición de una quinasa Jano mediante la administración de un compuesto de los que se describen en la presente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127329P | 2020-12-18 | 2020-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39567A true UY39567A (es) | 2022-07-29 |
Family
ID=79425773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039567A UY39567A (es) | 2020-12-18 | 2021-12-16 | Compuestos pirazol que contienen boro,composiciones que los comprenden, métodos y usos de los mismos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11827657B2 (es) |
| EP (1) | EP4263559A1 (es) |
| JP (1) | JP2023554665A (es) |
| CN (1) | CN117242080A (es) |
| AR (1) | AR124393A1 (es) |
| AU (1) | AU2021401834A1 (es) |
| CA (1) | CA3201608A1 (es) |
| MX (1) | MX2023007150A (es) |
| TW (1) | TW202239416A (es) |
| UY (1) | UY39567A (es) |
| WO (1) | WO2022133420A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117486916B (zh) * | 2023-12-29 | 2024-04-12 | 山东国邦药业有限公司 | 一种3,4,5-三氟苯硼酸的合成方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284652A (en) | 1977-01-24 | 1981-08-18 | The Quaker Oats Company | Matrix, product therewith, and process |
| US4327076A (en) | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
| US4609543A (en) | 1983-11-14 | 1986-09-02 | Nabisco Brands, Inc. | Soft homogeneous antacid tablet |
| US4935243A (en) | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
| US5827565A (en) | 1996-10-25 | 1998-10-27 | T.F.H. Publications, Inc. | Process for making an edible dog chew |
| US6086940A (en) | 1996-10-25 | 2000-07-11 | T.F.H. Publications, Inc. | High starch content dog chew |
| US6093427A (en) | 1997-09-03 | 2000-07-25 | T.F.H.Publications, Inc. | Vegetable-based dog chew |
| US6110521A (en) | 1996-10-25 | 2000-08-29 | T.F.H. Publications, Inc. | Wheat and casein dog chew with modifiable texture |
| US5753255A (en) | 1997-02-11 | 1998-05-19 | Chavkin; Leonard | Chewable molded tablet containing medicinally active substances |
| TR200003719T2 (tr) | 1998-06-19 | 2001-03-21 | Pfizer Products Inc. | Pirolo[2,3-d]Pirimidin bileşikleri |
| US6093441A (en) | 1998-07-15 | 2000-07-25 | Tfh Publications, Inc. | Heat modifiable peanut dog chew |
| US6270790B1 (en) | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
| US6387381B2 (en) | 1998-09-24 | 2002-05-14 | Ez-Med Company | Semi-moist oral delivery system |
| US6060078A (en) | 1998-09-28 | 2000-05-09 | Sae Han Pharm Co., Ltd. | Chewable tablet and process for preparation thereof |
| US6159516A (en) | 1999-01-08 | 2000-12-12 | Tfh Publication, Inc. | Method of molding edible starch |
| US20040151759A1 (en) | 2002-08-16 | 2004-08-05 | Douglas Cleverly | Non-animal product containing veterinary formulations |
| US20040037869A1 (en) | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
| US7955632B2 (en) | 2005-12-07 | 2011-06-07 | Bayer B.V. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
| LT2474545T (lt) | 2005-12-13 | 2017-02-27 | Incyte Holdings Corporation | Heteroarilu pakeisti pirolo[2,3-b]piridinai ir pirolo[2,3-b]pirimidinai kaip janus kinazės inhibitoriai |
| ATE550648T1 (de) | 2007-06-22 | 2012-04-15 | Genera Istrazivanja D O O | Adamts4 als blut-biomarker und therapeutisches ziel bei chronischem nierenversagen |
| TWI556741B (zh) | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
| DK2288610T3 (en) | 2008-03-11 | 2016-11-28 | Incyte Holdings Corp | Azetidinesulfonic AND CYCLOBUTANDERIVATER AS JAK INHIBITORS |
| PT2384326E (pt) | 2008-08-20 | 2014-06-09 | Zoetis Llc | Compostos de pirrolo[2,3-d]pirimidina |
| US8962608B2 (en) | 2011-09-22 | 2015-02-24 | Merck Sharp & Dohme Corp. | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
| HUE041514T2 (hu) | 2012-02-06 | 2019-05-28 | Merial Inc | Szisztémásan ható hatóanyagokat tartalmazó, parazitaellenes, szájon át adagolt állatgyógyászati készítmények, eljárások és alkalmazásuk |
| WO2014015107A1 (en) | 2012-07-20 | 2014-01-23 | Zoetis Llc | Dosing regimen for janus kinase (jak) inhibitors |
| WO2018108969A1 (en) | 2016-12-14 | 2018-06-21 | Intervet International B.V. | Aminopyrazoles as selective janus kinase inhibitors |
| WO2018111663A1 (en) * | 2016-12-14 | 2018-06-21 | Merck Sharp & Dohme Corp. | Aminopyrazoles as janus kinase inhibitors |
| CN113195476A (zh) | 2018-12-13 | 2021-07-30 | 英特维特国际股份有限公司 | 1-[(3r,4s)-4-氰基四氢吡喃-3-基]-3-[(2-氟-6-甲氧基-4-吡啶基)氨基]吡唑-4-甲酰胺的结晶形式 |
| CA3122183A1 (en) | 2018-12-13 | 2020-06-18 | Intervet International B.V. | Process for preparing 1-[(3r,4s)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]p yrazole-4-carboxamide |
| WO2020118597A1 (en) | 2018-12-13 | 2020-06-18 | Intervet International B.V. | Process for making 1- [ (3r, 4s) -4-cyanotetrahydropyran-3-yl] -3- [ (2-fluoro-6-methoxy-4-pyridyl) amino] pyrazole-4-carboxamide |
| CA3134750A1 (en) | 2019-04-24 | 2020-10-29 | Jingdan Hu | A 7h-pyrrolo[2,3-d]pyrimidine jak-inhibitor |
| JP2022532501A (ja) | 2019-05-02 | 2022-07-15 | インターベット インターナショナル ベー． フェー． | ラセミ混合物のキラル分離によるエチル３－アミノ－１－［（３ｒ，４ｓ）－４－シアノテトラヒドロピラン－３－イル］ピラゾール－４－カルボン酸塩の製造方法 |
-
2021
- 2021-12-13 WO PCT/US2021/072885 patent/WO2022133420A1/en active Application Filing
- 2021-12-13 EP EP21841168.4A patent/EP4263559A1/en active Pending
- 2021-12-13 US US17/644,023 patent/US11827657B2/en active Active
- 2021-12-13 CA CA3201608A patent/CA3201608A1/en active Pending
- 2021-12-13 MX MX2023007150A patent/MX2023007150A/es unknown
- 2021-12-13 CN CN202180093339.9A patent/CN117242080A/zh active Pending
- 2021-12-13 JP JP2023537471A patent/JP2023554665A/ja active Pending
- 2021-12-13 AU AU2021401834A patent/AU2021401834A1/en active Pending
- 2021-12-16 AR ARP210103537A patent/AR124393A1/es unknown
- 2021-12-16 UY UY0001039567A patent/UY39567A/es unknown
- 2021-12-17 TW TW110147436A patent/TW202239416A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202239416A (zh) | 2022-10-16 |
| CN117242080A (zh) | 2023-12-15 |
| CA3201608A1 (en) | 2022-06-23 |
| MX2023007150A (es) | 2023-09-04 |
| AU2021401834A1 (en) | 2023-07-06 |
| JP2023554665A (ja) | 2023-12-28 |
| US20220194965A1 (en) | 2022-06-23 |
| US11827657B2 (en) | 2023-11-28 |
| WO2022133420A1 (en) | 2022-06-23 |
| AR124393A1 (es) | 2023-03-22 |
| EP4263559A1 (en) | 2023-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2021000154A (es) | Compuestos de 3-carbonilamino-5-ciclopentil-1h-pirazol que tienen actividad inhibidoria en cdk2 | |
| CO2017000912A2 (es) | Derivados de 2 -h indazol como inhibidores de kinasas dependientes de ciclinas (cdk) y usos terapeuticos de los mismos | |
| CO2022016377A2 (es) | Inhibidores de kras tricíclicos fusionados | |
| PE20191303A1 (es) | Compuestos con actividad antitumoral contra celulas cancerosas que tienen mutaciones en el exon 20 de egfr o her2 | |
| AR066214A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas. usos y composiciones farmaceuticas | |
| NI201400102A (es) | Derivados macrocíclicos para el tratamiento de enfermedades proliferativas | |
| CL2020002146A1 (es) | Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer. | |
| BR112016015818A2 (pt) | Compostos e respectivos usos para tratar pacientes com células cancerosas mutantes em relação a ros1 | |
| CO2021015318A2 (es) | Compuestos y métodos para el tratamiento de covid-19 | |
| DOP2015000241A (es) | Compuestos de biaril-amida como inhibidores de cinasa | |
| CO2023007504A2 (es) | Derivados de carboxamida tricíclica como inhibidores de prmt5 | |
| CL2019001658A1 (es) | Derivados de la pirimidin enona tricíclica para la inhibición de rory y otros usos. | |
| DOP2023000285A (es) | Restos de administración terapéutica novedosos y usos de estos | |
| CL2021001388A1 (es) | Compuestos útiles en la terapia para el vih | |
| CL2022000005A1 (es) | Inhibidores de monoacilglicerol lipasa (magl) heterocíclicos | |
| CO2024001285A2 (es) | Compuestos tricíclicos como inhibidores de kras | |
| BR112021025764A2 (pt) | Derivado de pirimidina que inibe o crescimento de células cancerígenas e uso medicinal do mesmo | |
| UY39567A (es) | Compuestos pirazol que contienen boro,composiciones que los comprenden, métodos y usos de los mismos | |
| CL2021003032A1 (es) | Métodos de tratamiento de la urticaria crónica espontánea utilizando un inhibidor de la tirosina quinasa de bruton | |
| CL2020000271A1 (es) | Combinación terapéutica de un inhibidor tirosina quinasa del egfr y un inhibidor de quinasa dependiente de ciclina. | |
| CO2022015891A2 (es) | Administración conjunta de mirdametinib y lifirafenib para uso en el tratamiento de cánceres | |
| CL2022001887A1 (es) | Pirazolo-pirimidinas sustituidas y usos de las mismas | |
| CL2021001656A1 (es) | Compuestos de imidazopiridina e imidazopiridina y sus usos. | |
| CL2020000270A1 (es) | Combinación terapéutica de un inhibidor tirosina quinasa del egfr de tercera generación y un inhibidor raf. | |
| ECSP22098041A (es) | Inhibidores alostéricos de egfr y métodos de uso de estos |